AKTS

Aktis Oncology, Inc. Common stock

19.43

USD

-0.20

-1.02%

Sep 25, 15:58 UTC -4

Closed

After-Market

21.36

+1.93

+9.93%

Aktis Oncology, Inc. Common stock Profile

About

Aktis Oncology Inc. is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. Aktis Oncology Inc. is based in BOSTON.

Info & Links

CEO

Matthew Roden

Headquarters

17 DRYDOCK AVENUE, SUITE NO 17-401
BOSTON, MA 02210, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

Aktis Oncology, Inc. Common stock Statistics

Valuation Measures

Market Capitalization²

1.19B

Enterprise Value

1.11B

Enterprise Value/EBITDA(ttm)

-21.41

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

2.44

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

Profit Margin(ttm)

-320.34%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-8.60%

Return on Assets(ttm)

Income Statement

Revenue(ttm)

6.61M

Revenue Per Share(ttm)

0.12

Gross Profit(ttm)

6.61M

EBITDA(ttm)³

-51.64M

Net Income Available to Common(ttm)

-42.47M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

52-Week Change

S&P 500 52-Week Change

19.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

53.75M

Dividend Yield

0.00%

Float⁴

51.97M

% Held by Insiders

3.30%

% Held by Institutions

28.84%

Balance Sheet

Total Cash(mrq)

517.32M

Total Cash Per Share(mrq)

9.63

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

16.33%

Quick Ratio(mrq)

16.33%

Book Value Per Share(mrq)

8.76

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.81

Free Cash Flow(ytd)

-47.95M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.